drugset / Trial / NCT05505539
Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia
NaSingle-groupOpen-labelTreatment
Summary
This is a single center, open-label, interventional pilot study to assess the feasibility, safety, and preliminary efficacy of intralesional 5-FU injections for the treatment of oral leukoplakia (OL).
Timeline
- Start
- 2022-09-30
- Primary completion
- 2023-08-31
- Completion
- 2023-12-31
Outcome
Outcome not reported
Stopped: “Principal Investigator no longer with university.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fluorouracil | Small molecule | 0.25 ml | Other |
| Subject | fluorouracil | Small molecule | 50 mg/ml | Other |